Back to News
Market Impact: 0.12
Nuwellis Appoints Brian Johnson As Director Of Quality And Regulatory Affairs
Source: Nasdaq
Healthcare & BiotechManagement & GovernanceRegulation & Legislation
Nuwellis appointed Brian Johnson as Director of Quality and Regulatory Affairs. Johnson will lead the medical technology company's quality-management and regulatory functions, including quality systems and audits. The executive appointment is operationally relevant but is unlikely to materially affect near-term financial performance or valuation.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
NUWE0.25
More News
- Bitcoin pinned at $78k after October losses; Binance resumes withdrawals
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- NUBURU Completes Tekne Acquisition, Adding a $93 Million Defense & Dual-Use Program Portfolio and Advancing Expansion Across NATO and Allied Markets
- BTIG cuts Acumen Pharmaceuticals stock price target to $1 on trial results
- Jefferies raises West Pharmaceutical stock price target on HVP growth
- Microsoft's moolah mountain is more massive than ever. It just doesn't want the people who built it